A RIPK1-specific PROTAC degrader achieves potent antitumour activity by enhancing immunogenic cell death. Mannion et al

A RIPK1-specific PROTAC degrader achieves potent antitumour activity by enhancing immunogenic cell death. Mannion et al

Original data from the images and western blots from the paper: A RIPK1-specific PROTAC degrader achieves potent antitumour activity by enhancing immunogenic cell death.

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Tenev, Tencho
Format: Dataset
Sprache:eng
Schlagworte:
Cancer
Immune Checkpoint Inhibitor
Immunogenic Cell Death
Innate Immunity
Molecular Biology
Radiation
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Original data from the images and western blots from the paper: A RIPK1-specific PROTAC degrader achieves potent antitumour activity by enhancing immunogenic cell death.
DOI:10.17632/822syk52yw